Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
There are no standards requiring radiologists to report on the presence of BACs, even though up to half of referring providers have indicated they would prefer to be made aware of the finding.
Breast artery calcifications are already visible when radiologists review mammograms, but nothing typically happens with them. Researchers aimed to see if AI could help translate those findings into an easy-to-understand cardiovascular risk score.
Despite the great progress that has been made toward the clinical implementation of AI, new data caution against trusting the technology as a single reader in certain settings.
The Mount Sinai Robert F. Smith Mobile Prostate Cancer Screening Unit was developed with the intention of increasing access to screening and supporting prostate health in the Black community.
Those who received customized messages pertaining to their risk of developing colorectal cancer are 34% more likely to complete the screening than those who are offered standard referrals, research shows.
Non-white individuals and people living in less educated, lower income areas are more likely to receive an advanced lung cancer diagnosis, such as stage 4 disease.
Digital breast tomosynthesis exams produce fewer false positive results than standard two-dimensional mammography, though not substantially, experts shared recently in JAMA Open Network.
Extracolonic findings observed on computed tomography colonography scans of cancer patients might identify undetected malignancies more often than previously thought, according to a new study in Clinical Imaging.
Current bone age-based methods of growth prediction in children are inaccurate and frequently overestimate final height, experts explained in Radiology.